Patent · US Expired

Anxiolytic method

US4409223A · kind A · utility

4Cited by
2References
3Claims
0Family size

Inventors

Key dates

Filing dateAug 6, 1982
Grant dateOct 11, 1983
Priority date—
Expiry dateAug 6, 2002

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

1-(2-Pyrimidinyl)piperazine and its pharmaceutically acceptable salts are useful in the alleviation of anxiety.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.